<VariationArchive VariationID="554623" VariationName="NM_000478.6(ALPL):c.1017dup (p.His340fs)" VariationType="Duplication" Accession="VCV000554623" Version="10" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-02-28" DateCreated="2018-08-05" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="540890" VariationID="554623">
      <GeneList>
        <Gene Symbol="ALPL" FullName="alkaline phosphatase, biomineralization associated" GeneID="249" HGNC_ID="HGNC:438" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1p36.12</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="21508984" stop="21578410" display_start="21508984" display_stop="21578410" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="21835857" stop="21904904" display_start="21835857" display_stop="21904904" Strand="+" />
          </Location>
          <OMIM>171760</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000478.6(ALPL):c.1017dup (p.His340fs)</Name>
      <CanonicalSPDI>NC_000001.11:21575749:GGG:GGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p36.12</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="21575749" stop="21575750" display_start="21575749" display_stop="21575750" variantLength="1" positionVCF="21575749" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="21902242" stop="21902243" display_start="21902242" display_stop="21902243" variantLength="1" positionVCF="21902242" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <ProteinChange>H340fs</ProteinChange>
      <ProteinChange>H263fs</ProteinChange>
      <ProteinChange>H285fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.21902245dup" Assembly="GRCh37">
            <Expression>NC_000001.10:g.21902245dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127501.4" sequenceAccession="NM_001127501" sequenceVersion="4" change="c.852dup">
            <Expression>NM_001127501.4:c.852dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001120973.2" sequenceAccession="NP_001120973" sequenceVersion="2" change="p.His285fs">
            <Expression>NP_001120973.2:p.His285fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177520.3" sequenceAccession="NM_001177520" sequenceVersion="3" change="c.786dup">
            <Expression>NM_001177520.3:c.786dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001170991.1" sequenceAccession="NP_001170991" sequenceVersion="1" change="p.His263fs">
            <Expression>NP_001170991.1:p.His263fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369803.2" sequenceAccession="NM_001369803" sequenceVersion="2" change="c.1017dup">
            <Expression>NM_001369803.2:c.1017dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356732.1" sequenceAccession="NP_001356732" sequenceVersion="1" change="p.His340fs">
            <Expression>NP_001356732.1:p.His340fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369804.2" sequenceAccession="NM_001369804" sequenceVersion="2" change="c.1017dup">
            <Expression>NM_001369804.2:c.1017dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356733.1" sequenceAccession="NP_001356733" sequenceVersion="1" change="p.His340fs">
            <Expression>NP_001356733.1:p.His340fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369805.2" sequenceAccession="NM_001369805" sequenceVersion="2" change="c.1017dup">
            <Expression>NM_001369805.2:c.1017dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356734.1" sequenceAccession="NP_001356734" sequenceVersion="1" change="p.His340fs">
            <Expression>NP_001356734.1:p.His340fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.21575752dup" Assembly="GRCh38">
            <Expression>NC_000001.11:g.21575752dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008940.1" sequenceAccession="NG_008940" sequenceVersion="1" change="g.71388dup">
            <Expression>NG_008940.1:g.71388dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000478.6" sequenceAccession="NM_000478" sequenceVersion="6" change="c.1017dup" MANESelect="true">
            <Expression>NM_000478.6:c.1017dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000469.3" sequenceAccession="NP_000469" sequenceVersion="3" change="p.His340fs">
            <Expression>NP_000469.3:p.His340fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000478.6" sequenceAccession="NM_000478" sequenceVersion="6" change="c.1017dupG" MANESelect="true">
            <Expression>NM_000478.6:c.1017dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="764908423" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000478.6(ALPL):c.1017dup (p.His340fs) AND Infantile hypophosphatasia" Accession="RCV000670296" Version="1">
        <ClassifiedConditionList TraitSetID="3766">
          <ClassifiedCondition DB="MedGen" ID="C0268412">Infantile hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2017-10-27" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.1017dup (p.His340fs) AND not provided" Accession="RCV001044816" Version="5">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-26" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.1017dup (p.His340fs) AND Hypophosphatasia" Accession="RCV001275109" Version="1">
        <ClassifiedConditionList TraitSetID="8894">
          <ClassifiedCondition DB="MedGen" ID="C0020630">Hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-09-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.1017dup (p.His340fs) AND multiple conditions" Accession="RCV002499170" Version="1">
        <ClassifiedConditionList TraitSetID="9473">
          <ClassifiedCondition DB="MedGen" ID="C0268413">Adult hypophosphatasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0220743">Childhood hypophosphatasia</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268412">Infantile hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-20" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000478.6(ALPL):c.1017dup (p.His340fs) AND Adult hypophosphatasia" Accession="RCV003465497" Version="1">
        <ClassifiedConditionList TraitSetID="3768">
          <ClassifiedCondition DB="MedGen" ID="C0268413">Adult hypophosphatasia</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-26" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2018-08-05" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10679946</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3174660</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31760938</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">32973344</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">33814268</ID>
        </Citation>
        <DescriptionHistory Dated="2020-04-15">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9473" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2390" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Infantile hypophosphatasia</ElementValue>
                <XRef ID="Infantile+hypophosphatasia/8660" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009427" DB="MONDO" />
                <XRef ID="55236002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HOPS</ElementValue>
                <XRef Type="MIM" ID="241500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247651" DB="Orphanet" />
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0268412" DB="MedGen" />
              <XRef Type="MIM" ID="241500" DB="OMIM" />
            </Trait>
            <Trait ID="2275" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adult hypophosphatasia</ElementValue>
                <XRef ID="Adult+hypophosphatasia/7639" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007798" DB="MONDO" />
                <XRef ID="20756002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247676" DB="Orphanet" />
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0268413" DB="MedGen" />
              <XRef Type="MIM" ID="146300" DB="OMIM" />
            </Trait>
            <Trait ID="2389" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Childhood hypophosphatasia</ElementValue>
                <XRef ID="Hypophosphatasia+childhood/3678" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009428" DB="MONDO" />
                <XRef ID="30174008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HHRH</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="8735" />
                <XRef ID="8735" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247667" DB="Orphanet" />
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0220743" DB="MedGen" />
              <XRef Type="MIM" ID="241510" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="8894" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="14484" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hypophosphatasia</ElementValue>
                <XRef ID="23875" DB="GeneTests" />
                <XRef ID="Hypophosphatasia/3677" DB="Genetic Alliance" />
                <XRef ID="MONDO:0018570" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Phosphoethanol-aminuria</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6734" />
                <XRef ID="6734" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0020630" DB="MedGen" />
              <XRef ID="MONDO:0018570" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3768" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2275" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Adult hypophosphatasia</ElementValue>
                <XRef ID="Adult+hypophosphatasia/7639" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007798" DB="MONDO" />
                <XRef ID="20756002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247676" DB="Orphanet" />
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0268413" DB="MedGen" />
              <XRef Type="MIM" ID="146300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3766" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2390" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Infantile hypophosphatasia</ElementValue>
                <XRef ID="Infantile+hypophosphatasia/8660" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009427" DB="MONDO" />
                <XRef ID="55236002" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">HOPS</ElementValue>
                <XRef Type="MIM" ID="241500" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Hypophosphatasia is characterized by defective mineralization of growing or remodeling bone, with or without root-intact tooth loss, in the presence of low activity of serum and bone alkaline phosphatase. Clinical features range from stillbirth without mineralized bone at the severe end to pathologic fractures of the lower extremities in later adulthood at the mild end. While the disease spectrum is a continuum, seven clinical forms of hypophosphatasia are usually recognized based on age at diagnosis and severity of features: Perinatal (severe): characterized by pulmonary insufficiency and hypercalcemia. Perinatal (benign): prenatal skeletal manifestations that slowly resolve into one of the milder forms. Infantile: onset between birth and age six months of clinical features of rickets without elevated serum alkaline phosphatase activity. Severe childhood (juvenile): variable presenting features progressing to rickets. Mild childhood: low bone mineral density for age, increased risk of fracture, and premature loss of primary teeth with intact roots. Adult: characterized by stress fractures and pseudofractures of the lower extremities in middle age, sometimes associated with early loss of adult dentition. Odontohypophosphatasia: characterized by premature exfoliation of primary teeth and/or severe dental caries without skeletal manifestations.</Attribute>
                <XRef ID="NBK1150" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301329</ID>
                <ID Source="BookShelf">NBK1150</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="pmc">3061990</ID>
              </Citation>
              <XRef ID="247651" DB="Orphanet" />
              <XRef ID="436" DB="Orphanet" />
              <XRef ID="C0268412" DB="MedGen" />
              <XRef Type="MIM" ID="241500" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1545434" SubmissionDate="2018-07-10" DateLastUpdated="2018-08-05" DateCreated="2018-08-05">
        <ClinVarSubmissionID localKey="1720758|OMIM:241500" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000795131" DateUpdated="2018-08-05" DateCreated="2018-08-05" Type="SCV" Version="1" SubmitterName="Counsyl" OrgID="320494" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-10-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Counsyl Autosomal Recessive and X-Linked Classification Criteria (2018)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/sbjulxjt/counsyl_autosomal_recessive_and_x-linked_classification_criteria_2018_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALPL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="1" alternateAllele="CG" referenceAllele="C" start="21902242" stop="21902242" variantLength="1" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.4:c.1017dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241500" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB4282047</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2875159" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_000478.6:c.1017dupG|Hypophosphatasia" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001459884" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.6:c.1017dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Hypophosphatasia</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2373919" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-04-15">
        <ClinVarSubmissionID localKey="6675061|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001208635" DateUpdated="2024-02-20" DateCreated="2020-04-15" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-26">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">3174660</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10679946</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">32973344</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">33814268</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31760938</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.His340Alafs*3) in the ALPL gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALPL are known to be pathogenic (PMID: 3174660, 10679946, 32973344, 33814268). This variant is present in population databases (rs764908423, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with autosomal recessive hypophosphatasia (PMID: 31760938). ClinVar contains an entry for this variant (Variation ID: 554623). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ALPL" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000001.10:g.21902242_21902243insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5464601" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_000478.6:c.1017dup|OMIM:146300;241500;241510" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002813996" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.6:c.1017dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="146300" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241500" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="241510" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7845214" SubmissionDate="2023-12-07" DateLastUpdated="2023-12-30" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_000478.6:c.1017dup|OMIM:146300" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004191892" DateUpdated="2023-12-30" DateCreated="2023-12-30" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000478.6:c.1017dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="146300" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5464601" TraitType="Disease" MappingType="XRef" MappingValue="241500" MappingRef="OMIM">
        <MedGen CUI="C0268412" Name="Infantile hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2875159" TraitType="Disease" MappingType="Name" MappingValue="Hypophosphatasia" MappingRef="Preferred">
        <MedGen CUI="C0020630" Name="Hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5464601" TraitType="Disease" MappingType="XRef" MappingValue="241510" MappingRef="OMIM">
        <MedGen CUI="C0220743" Name="Childhood hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1545434" TraitType="Disease" MappingType="XRef" MappingValue="241500" MappingRef="OMIM">
        <MedGen CUI="C0268412" Name="Infantile hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7845214" TraitType="Disease" MappingType="XRef" MappingValue="146300" MappingRef="OMIM">
        <MedGen CUI="C0268413" Name="Adult hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5464601" TraitType="Disease" MappingType="XRef" MappingValue="146300" MappingRef="OMIM">
        <MedGen CUI="C0268413" Name="Adult hypophosphatasia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2373919" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

